Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples